Presidio Pharmaceuticals, Inc.

United States of America

 
Total IP 18
Total IP Rank # 82,943
IP Activity Score 0/5.0    0
IP Activity Rank # 1,661,095

Patents

Trademarks

2 0
1 0
15 0
0
 
Last Patent 2015 - Solid forms comprising inhibitor...
First Patent 2006 - 3,4-disubstituted coumarin and q...

Latest Inventions, Goods, Services

2014 Invention Inhibitors of hcv ns5a. Provided herein are compounds, pharmaceutical compositions and combinati...
2013 Invention Inhibitors of hepatitis c virus. A class of compounds that inhibit Hepatitis C Virus (HCV) is dis...
Invention Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith. This in...
Invention Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith. This inv...
2012 Invention Inhibitors of hcv ns5a. Provided herein are compounds, pharmaceutical compositions, and combinati...
Invention Solid forms comprising an inhibitor of hcv ns5a, compositions thereof, and uses therewith. Solid ...
2011 Invention Inhibitors of hepatitis c virus. A class of compounds that inhibit Hepatitis C Virus (HCV) is di...
Invention Tricyclic fused ring inhibitors of hepatitis c. Provided herein are compounds, pharmaceutical com...
Invention Substituted bicyclic hcv inhibitors. Provided herein are compounds, pharmaceutical compositions a...
Invention Inhibitors of hcv ns5a protein. Antiviral compounds may be used to inhibit or reduce the activit...
Invention Inhibitors of hcv ns5a protein. Antiviral compounds may be used to inhibit or reduce the activity...
Invention Inhibitors of hcv ns5a protein. Provided herein are compounds, pharmaceutical compositions and co...
Invention Inhibitors of hcv ns5a. Provided herein are compounds, pharmaceutical compositions and combinatio...
2010 Invention Fused ring inhibitors of hepatitis c. Provided herein are compounds of Formula I, pharmaceutical ...
Invention Fused ring inhibitors of hepatitis c. Provided herein are compounds, pharmaceutical compositions ...
2009 Invention Inhibitors of hcv ns5a. The invention relates to non-macrocyclic, non-peptidic, substituted heter...
Invention Inhibitors of hcv ns5a. Provided herein is a compound having the general formula (see above formu...
2006 Invention 3,4-disubstituted coumarin and quinolone compounds. The present invention relates to 3,4-disubsti...